Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
2013 1
2018 1
2019 2
2020 4
2021 2
2022 7
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022.
Bihan K, Lipszyc L, Lemaitre F, Dautriche A, Fédrizzi S, Atzenhoffer M, Vitores A, Page A, Lebrun-Vignes B. Bihan K, et al. Among authors: atzenhoffer m. Therapie. 2023 Sep-Oct;78(5):531-547. doi: 10.1016/j.therap.2023.03.001. Epub 2023 Mar 7. Therapie. 2023. PMID: 37012153 Free PMC article.
Vaccines and Bell's palsy: A narrative review.
Bertin B, Grenet G, Pizzoglio-Billaudaz V, Lepelley M, Atzenhoffer M, Vial T. Bertin B, et al. Among authors: atzenhoffer m. Therapie. 2023 May-Jun;78(3):279-292. doi: 10.1016/j.therap.2022.07.009. Epub 2022 Aug 1. Therapie. 2023. PMID: 36038397 Free PMC article. Review.
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.
Moulis G, Crickx E, Thomas L, Massy N, Mahévas M, Valnet-Rabier MB, Atzenhoffer M, Michel M, Godeau B, Bagheri H, Salvo F; French Covigilance COVID-19 Vaccine-ITP Study Group. Moulis G, et al. Among authors: atzenhoffer m. Blood. 2022 Apr 21;139(16):2561-2565. doi: 10.1182/blood.2022015470. Blood. 2022. PMID: 35446373 Free PMC article. No abstract available.
Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database.
Martin M, Nguyen HM, Beuvon C, Bene J, Palassin P, Atzenhoffer M, Rouby F, Sassier M, Pérault-Pochat MC, Roblot P, Allouchery M, Puyade M; French Network of Regional Pharmacovigilance Centers. Martin M, et al. Among authors: atzenhoffer m. Cancers (Basel). 2022 Oct 14;14(20):5030. doi: 10.3390/cancers14205030. Cancers (Basel). 2022. PMID: 36291814 Free PMC article.
[COVID-19 and adenovirus vaccines: French experience of enhanced pharmacovigilance].
Massy N, Atzenhoffer M, Boulay C, Pecquet PE, Ledys F, Cracowski JL, Masmoudi K, Lepelley M, Gras-Champel V. Massy N, et al. Among authors: atzenhoffer m. Therapie. 2023 Sep-Oct;78(5):489-498. doi: 10.1016/j.therap.2023.01.005. Epub 2023 Jan 21. Therapie. 2023. PMID: 36759287 Free PMC article. French.
Drug-Induced Uveitis Related to Checkpoint Inhibitors and MAP-kinase Inhibitors.
Thibault T, Ben Ghezala I, Freppel R, Rajillah A, Boulay C, Brunel P, Atzenhoffer M, Auvens C, Devilliers H, Grandvuillemin A. Thibault T, et al. Among authors: atzenhoffer m. Ophthalmology. 2024 Feb;131(2):249-251. doi: 10.1016/j.ophtha.2023.10.004. Epub 2023 Oct 10. Ophthalmology. 2024. PMID: 37820932 No abstract available.
Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitors.
Velev M, Baroudjian B, Pruvost R, De Martin E, Laparra A, Babai S, Teysseire S, Danlos FX, Albiges L, Bernigaud C, Benderra MA, Pradère P, Zaidan M, Decroisette C, Fallah F, Matergia G, Lavaud P, Jantzem H, Atzenhoffer M, Buyse V, Ammari S, Robert C, Champiat S, Messayke S, Marabelle A, Guettier C, Lebbe C, Lambotte O, Michot JM. Velev M, et al. Among authors: atzenhoffer m. Eur J Cancer. 2023 Jan;179:28-47. doi: 10.1016/j.ejca.2022.11.001. Epub 2022 Nov 12. Eur J Cancer. 2023. PMID: 36473326
19 results